tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Replimune Group Inc (REPL)
NASDAQ:REPL
US Market
REPL
Replimune Group
RESEARCH TOOLSreports

Replimune Group (REPL) Stock News & Sentiment

Compare
471 Followers
Replimune amends Hercules loan, strengthens funding runway
Premium
Company Announcements
Replimune amends Hercules loan, strengthens funding runway
3d ago
8K
REPL
Replimune Highlights RP1, RP2 Progress Ahead of JPM Conference
Premium
Company Announcements
Replimune Highlights RP1, RP2 Progress Ahead of JPM Conference
25d ago
8K
REPL
Replimune Group Reports Increased Losses Amid R&D Expansion
Premium
Company Announcements
Replimune Group Reports Increased Losses Amid R&D Expansion
3M ago
REPL
Positive Outlook for Replimune Group: Buy Rating Affirmed on Promising RP1 + Opdivo Therapy and Strong Financial Position
Premium
Ratings
Positive Outlook for Replimune Group: Buy Rating Affirmed on Promising RP1 + Opdivo Therapy and Strong Financial Position
3M ago
REPL
Replimune’s Promising Study on Metastatic Uveal Melanoma: A Potential Game Changer?
Premium
Company Announcements
Replimune’s Promising Study on Metastatic Uveal Melanoma: A Potential Game Changer?
3M ago
REPL
Replimune’s RP2 Study: A Promising Step in Cancer Immunotherapy
Premium
Company Announcements
Replimune’s RP2 Study: A Promising Step in Cancer Immunotherapy
3M ago
REPL
Replimune’s Phase 3 Study on Advanced Melanoma: A Potential Game-Changer?
Premium
Company Announcements
Replimune’s Phase 3 Study on Advanced Melanoma: A Potential Game-Changer?
3M ago
REPL
More REPL News >

REPL News on the Web

REPL: Wedbush Maintains 'Outperform' Rating and Raises Price Target | REPL Stock News
GuruFocus News
Bullish
Replimune (REPL) Awaits FDA Approval for RP1 in Melanoma Treatment
GuruFocus News
Bullish
Replimune Group (REPL) Receives a Hold from BMO Capital
TipRanks News
Bearish
Why Replimune Group, Inc.’s (REPL) Stock Is Down 5.39%
AAII
Neutral
Replimune Highlights RP1, RP2 Progress Ahead of JPM Conference
TipRanks News
Neutral
Why Replimune Group, Inc.’s (REPL) Stock Is Down 5.27%
AAII
Neutral
Why Replimune Group, Inc.’s (REPL) Stock Is Down 6.07%
AAII
Neutral
Why Replimune Group, Inc.’s (REPL) Stock Is Down 5.66%
AAII
Neutral

News Score - Last 7 Days

Positive
REPL
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average73%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is REPL’s Media Buzz Sentiment?
2 articles about REPL were published this week. In an average week, 1.25 articles are published.
    What is REPL’s weekly average amount of articles?
    In an average week, 1.25 articles about REPL are published.
      What is REPL’s News Sentiment?
      100% of articles about REPL were positive this week, compared to its sector average of 73%.
        Healthcare Stocks that are Trending in the News
        DVADaVita
        TECHBio-Techne
        PLXProtalix
        VSTMVerastem
        RMDResmed
        Showing the stocks with the most bullish news sentiment over the past week